Quick Answer
REVELATION BIOSCIENCES, INC. reported Total Assets of $11.58 million for the year ending 2025.
- REVELATION BIOSCIENCES, INC. showed an increase of +74.9% in Total Assets from 2024 to 2025.
- This data is from REVELATION BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $3.50 million | Q1 2021: $74.03 million | Q2 2021: $73.89 million | Q3 2021: $73.56 million | Q1 2022: $7.98 million | Q2 2022: $4.15 million | Q3 2022: $6.60 million | Q1 2023: $18.12 million | Q2 2023: $16.04 million | Q3 2023: $14.22 million | Q1 2024: $14.70 million | Q2 2024: $12.27 million | Q3 2024: $6.74 million | Q1 2025: $3.97 million | Q2 2025: $5.40 million | Q3 2025: $12.86 million.
- Over the full 7 years of available data (2019 to 2025), REVELATION BIOSCIENCES, INC.'s Total Assets has grown by 50,991.4%.
- Historical annual values: Fiscal year 2025: $11.58 million | Fiscal year 2024: $6.62 million | Fiscal year 2023: $12.21 million | Fiscal year 2022: $5.50 million | Fiscal year 2021: $2.04 million | Fiscal year 2020: $74.16 million | Fiscal year 2019: $22.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: